6-K
Report of Foreign Issuer
Zoar Ltd Filed Acc 0001493152-26-053003
Zoar Limited Completes Business Combination with Impact Biomedical Inc.
- Zoar Limited ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “ZOAR” on November 18, 2026.
From the SEC's structured data for this filing
Loading form6-k.htm…